Skip to content

CHYM

NASDAQ

Chime Financial Inc

Financials
Financial Services
Report Card

CHYM at a glance — five pillars scored 0–100 from real filed financials.

Value
Growth
Profitability
0
Health
0
Dividends
0

Overall: Unrated · 0/100. A wider, greener shape means more pillars look healthy. Dividends scores 0 when a company pays none — that is a choice, not a flaw.

Key Metrics

Market Cap

$0.00

P/E

Forward P/E (est.)

ROE

Revenue Growth

EPS Growth

Profit Margin

FCF Yield

Debt / Equity

ROIC

-57.0%

Interest Coverage

Current Ratio

5.07x

Dividend Yield

Implied Growth (rev. DCF)

Rating Score

0/100

Business Overview
Research

Chime Financial Inc (CHYM) is a small-cap company in the Financial Services industry, part of the Financials sector of the S&P 500.

In its latest reported year it generated about $2.19B in revenue and posted a net loss of $1.01B.

Our model rates CHYM Unrated (0/100) on growth, profitability, financial health, and valuation. The summary below is built from its filed financials and current ratios and refreshes automatically.

Revenue Growth
Research

2Y CAGR

30.8%

Revenue moved from $1.28B in 2023 to $2.19B in 2025, a 30.8% compound annual growth rate. The most recent year was roughly steady year over year. Slower, mature growth is common for established businesses.

Profitability
0/1 checks passedROIC above 10%

Gross Margin

88.0%

Operating Margin

-47.6%

Net Margin

-46.2%

ROE

Debt Analysis
Research
1/1 checks passedShort-term bills covered

Total Debt

Net Debt

Net Debt / EBITDA

Debt / Equity

Leverage: debt-to-equity is n/a, with a current ratio of 5.1x. Detailed balance-sheet leverage is limited for this name.

Cash Flow Analysis
Research

Operating CF

$52.78M

Free Cash Flow

$32.89M

FCF Margin

1.5%

In the latest year Chime Financial Inc produced about $52.78M of operating cash flow and $32.89M of free cash flow after capital spending. Cash flow is what ultimately pays shareholders, so it is worth tracking over time.

Valuation Analysis
Research

P/E

P/S

P/B

EV / EBITDA

CHYM trades at n/a trailing earnings. With no positive trailing earnings, value it on sales, cash flow, or growth rather than P/E.

DCF Fair Value (Educational)

A two-stage discounted cash flow on real SEC-filed free cash flow — the intrinsic-value anchor professional analysts triangulate from.

DCF fair value / share

Current price

Starting FCF (latest 10-K)

$32.89M

Growth, years 1–5

4.0%

Fade to terminal, years 6–10

2.5%

Discount rate

9.0%

PV of 10-yr free cash flow$254.22M
PV of terminal value$310.52M
Estimated equity value$564.74M

Cash flows grow at the stage-1 rate (trailing revenue growth, capped at 20%) for five years, fade to 2.5% by year 10, and continue at that rate forever (Gordon terminal value), all discounted at 9.0%. Small changes in assumptions move the result a lot — treat this as one reference point, not a target price. Educational only, not investment advice.

Metrics vs. Sector Range

Where CHYM sits versus its Financials sector peers in the S&P 500.

TTM P/E
Forward P/E
P/S ratio
Revenue growth
EPS growth
Gross margin
88.0%Strong
Net margin
ROE

Bands show the middle half (25th–75th percentile) of the 60 Financials companies in the S&P 500 — the peer-relative anchor professional comps analysis uses. Context only — not investment advice.

Sector Peer Comparison

How CHYM stacks up against its Financials peers — valuation, profitability, and growth versus the sector median.

In the Financials sector (161 S&P 500 companies), CHYM ranks #87 of 161 by our overall rating.

P/E vs sector

median 16.6x

ROE vs sector

median 14.6%

Growth vs sector

median 9.4%

Sector rank

#87

of 161 by rating

CompanyP/ERev Gr.Rating
CHYMThis stockNot rated
ACTNot rated
AFRMNot rated
ARCCNot rated
ATLCNot rated
BGCNot rated
BULLNot rated
CACCNot rated
Financials median16.6x9.4%0/100
Compare side by side

Peers are the closest Financials companies by sub-industry and size. Sector median is across all 161 S&P 500 names in the sector. Educational, not a recommendation.

Bull Case

The case for CHYM:

  • As an established S&P 500 member in Financials, it brings scale and a long operating history.
Bear Case

The case against CHYM:

  • Like any single stock, it is exposed to competition, the economic cycle, and shifts in its end markets.
Key Risks
Research

Market risk — sector rotation, the economic cycle, and broad sentiment move the stock regardless of fundamentals.

Investment Thesis
Research

On balance, the picture is mixed: Chime Financial Inc is a small-cap financials business growing at a mature pace, with modest profitability, and a heavier debt load to watch. It trades at n/a earnings, which our model scores Unrated (0/100). Weigh this against your own goals and time horizon — this is educational information, not a recommendation.

CHYM — frequently asked questions

Is CHYM a good stock to buy?

We don't give buy or sell advice. Review Chime Financial Inc's fundamentals, valuation, and 5-year financials on this page, then make your own decision — and consider a licensed professional.

Where does CHYM's data come from?

Live price data plus real fundamentals and 5-year financials pulled directly from Chime Financial Inc's SEC filings — refreshed automatically, not hand-entered.

How is the 5-year projection for CHYM calculated?

It's a scenario model: it grows revenue at an assumed rate, applies a profit margin and a valuation multiple, and shows the resulting share-price range. The assumptions are yours to change — it's a tool for thinking, not a prediction.

Is this CHYM analysis financial advice?

No. Everything on this page is educational research, not financial advice or a recommendation to buy or sell CHYM. Always do your own research and consider a licensed professional.

Data notice. Fundamentals and financial statements are sourced from company filings (SEC EDGAR) and market-data providers; prices and market caps refresh on trading days and may be delayed. Ratings, projections, technical signals, and written summaries are model- or rule-generated for education and may simplify or lag the latest filings.

Not advice. Nothing on this page is investment advice or a recommendation to buy, hold, or sell any security. Do your own research and consult a licensed financial professional before investing.